Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jinf.2020.04.031 http://scihub22266oqcxt.onion/10.1016/j.jinf.2020.04.031 32360497!7189187!32360497     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Infect 2020 ; 81 (2): 318-356 Nephropedia Template TP {{tp|p=32360497|t=2020. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France |pdf=|usr=}}{{32360497}} gab.com Text The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France JO: J Infect http://www.kidney.de/pget.php?&tw=1&pmid=32360497 #FOAvip A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy. Twit Text FOAVip The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France ????J Infect http://www.kidney.de/pget.php?&tw=1&pmid=32360497 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32360497 #FOAvip English Wikipedia <ref>{{Cite pmid|32360497}}</ref> The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France #MMPMID32360497 Dimeglio C; Loubes JM; Deporte B; Dubois M; Latour J; Mansuy JM; Izopet J J Infect 2020[Aug]; 81 (2): 318-356 PMID32360497show ga A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy. |*Betacoronavirus[MESH] |*Infection Control/methods[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology/prevention & control/transmission[MESH] |France/epidemiology[MESH] |Humans[MESH] |Models, Statistical[MESH] |Pandemics/*prevention & control/statistics & numerical data[MESH] |Pneumonia, Viral/*epidemiology/prevention & control/transmission[MESH] |SARS-CoV-2[MESH]The SARS-CoV-2 seroprevalence is the key factor for deconfinement in F(epmc).pdf DeepDyve Pubget Overpricing